12:05 PM EST, 02/28/2025 (MT Newswires) -- The European stock markets closed mixed in Friday trading as the Stoxx Europe 600 was off 0.11%, Germany's DAX declined 0.25%, the FTSE 100 in London rose 0.61%, France's CAC 40 was up 0.11%, and the Swiss Market Index gained 0.36%.

In Germany, the estimated annual inflation rate for February is 2.3%, down from 2.6% the previous month while core inflation, which excludes food and energy, is estimated at 2.6%. Monthly inflation was estimated at 0.4%.

In France, annual inflation is expected to be 0.8% in February, down from 1.7% in January, according to the provisional estimates from the Institute for Statistics and Economic Studies, which said it is the first time in four years that the annual inflation rate was below 1%. Compared with the previous month, inflation for February is expected to be flat after rising 0.2% in January.

In the UK, the average price of a house rose 3.9% in February compared with a year earlier to 270,493 pounds ($340,427), according to the Nationwide House Price Index.

And in corporate news, shares of Teleperformance fell 7.5% in Paris after the French business process outsourcing company said it expects 2025 EBITA margins to be flat to up 0.1%.

Moderna said Friday it has obtained marketing authorization from the UK's Medicines and Healthcare products Regulatory Agency for mRESVIA, its respiratory syncytial virus vaccine for adults 60 and over.

Belgian biopharmaceutical company Argenx's Q4 sales of $737 million, up 29% quarter-on-quarter, were backed by increasing Vyvgart usage through prescriber breadth and depth, Oppenheimer said in a note to clients Friday.